Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases (Q38807704)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 May 2017

Language	Label	Description	Also known as
English	Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases	scientific article published on 2 May 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

author name string

Kamran A Ahmed

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sungjune Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

John Arrington

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Arash O Naghavi

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Thomas J Dilling

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Ben C Creelan

6

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Scott J Antonia

7

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Jimmy J Caudell

8

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Louis B Harrison

9

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Solmaz Sahebjam

10

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Jhanelle E Gray

11

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Arnold B Etame

12

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Peter A Johnstone

13

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Michael Yu

14

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Bradford A Perez

15

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

publication date

2 May 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

133

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

331-338

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Identification of prognostic factors in patients with brain metastases: a review of 1292 patients

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Pembrolizumab for the treatment of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Ipilimumab and radiation therapy for melanoma brain metastases

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Maximizing tumor immunity with fractionated radiation

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Analysis of long-term outcomes and prognostic factors in patients with non-small cell lung cancer brain metastases treated by gamma knife radiosurgery

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Gamma knife radiosurgery and brain metastases: local control, survival, and quality of life

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Gamma knife radiosurgery for treatment of cerebral metastases from non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Outcome of stereotactic radiosurgery for patients with non-small cell lung cancer metastatic to the brain

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Treatment outcomes using CyberKnife for brain metastases from lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Combining radiation and immunotherapy: a new systemic therapy for solid tumors?

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Radiotherapy and immune checkpoints inhibitors for advanced melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-017-2437-5

21 January 2018

Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28466250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/28466250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-017-2437-5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38807704&oldid=2202092959"